Brief: Akeso Sees Profit Of Not Less Than RMB1.85 Billion During Year
05/03/2024 01:28
March 5 (Reuters) - Akeso 9926.HK :
* SEES PROFIT OF NOT LESS THAN RMB1.85 BILLION DURING YEAR
* EXPECTED RESULTS DUE TO SIGNIFICANT INCREASE IN NUMBER OF
PATIENTS AND STEADY GROWTH IN PRODUCT SALES IN 2023, AMONG
OTHERS
Further company coverage: 9926.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akeso
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Akeso drops most in nearly three months on discounted share sale
Brief: Akeso To Place 20 Million New Shares At HK$97.76 Per Share
Factbox: Major drugmakers turn to China for licensing deals